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Abstract: The functional and psychosocial impact of facial paralysis on the patient is signifi-
cant. In response, a broad spectrum of treatment options exist and are provided by a multitude 
of health care practitioners. The cause and duration of the facial weakness can vary widely 
and the optimal care pathway varies. To optimize patient outcome, those involved in the care 
of patients with facial palsy should collaborate within comprehensive multidisciplinary teams 
(MDTs). At an international level, those involved in the care of patients with facial paralysis 
should aim to create standardized guidelines on which outcome domains matter most to patients 
to aid the identification of high quality care. This review summarizes the causes and treatment 
options for facial paralysis and discusses the subsequent importance of multidisciplinary care 
in the management of patients with this condition. Further discussion is given to the extended 
role of the MDT in determining what constitutes quality in facial palsy care to aid the creation 
of accepted care pathways and delineate best practice.
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Introduction
Facial palsy is characterized by weakness of the mimetic facial musculature. The 
potential spectrum of paralysis can range from a single, unilateral facial region being 
affected to a dense, bilateral facial paralysis characterized by a complete loss of 
dynamic facial expression. The majority of cases of facial paralysis are acquired with 
an estimated incidence of 118,000 cases in the USA per annum.1
The focus of pathology centers on the facial nerve (cranial nerve VII). As such, a 
myriad of additional end organs can be affected according to the location of the lesion 
along the length of the facial nerve. A proximal facial nerve lesion, for example, can 
result in ipsilateral hyperacusis, altered taste sensation in the anterior two-thirds of 
the tongue, and keratoconjunctivitis sicca.
An additional factor in determining a patient’s symptoms and long-term outcome 
relates to the varying potential for facial nerve recovery. Facial paralysis can arise from 
a broad spectrum of different etiologies, each with their own potential for spontaneous 
reneurotization.2–4 Furthermore, additional patient morbidity can arise from mimetic 
muscle reinnvervation. Both synkinesis (involuntary movements accompanying volun-
tary movements) and hyperkinesis (muscle tightness and hypertonia) can occur when 
the facial nerve regenerates in an aberrant manner.5–7
Consequent to the extensive etiological base of facial paralysis, patients can present 
for their primary review to a multitude of different health care professionals. These 
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include primary care physicians, neurologists, pediatricians, 
otolaryngologists, ophthalmologists maxillofacial, or plas-
tic and reconstructive surgeons. Despite this, each patient 
requires comprehensive care from a broad range of health 
care professionals to optimize their appearance, functional, 
and psychosocial outcomes.8 An effective facial palsy mul-
tidisciplinary team (MDT) should be equipped to provide 
the full breadth of patient care that considers the cause and 
potential longevity of the condition.
Facial palsy management overview
The need for multidisciplinary care in the management of 
patients with facial palsy centers on the spectrum of invasive 
and noninvasive interventions available. In addition, the etiol-
ogy and chronicity of the facial nerve dysfunction determine 
which treatment options are appropriate.
Invasive options include surgical procedures that support 
the facial soft tissues (static) or those that reanimate facial 
movements (dynamic) along with procedures designed to 
paralyze parts of the unaffected side of the face to restore 
symmetry. Direct repair of the facial nerve was first reported 
in the year 1821.9,10 From this point, an increasing understand-
ing of the capacity for neural regeneration following injury, 
along with the use of nerve grafts and transfers created the 
potential for reinnervating native facial musculature with 
the potential to function.11–13 These procedures were, how-
ever, unsuitable in those whose facial musculature had been 
dennervated for a more prolonged period of time and showed 
little activity on neurophysiological testing.14 At this stage, 
degeneration of the neuromuscular junction has occurred and 
an irreversible process of atrophy and fibrosis renders the 
native facial musculature nonfunctional. In these situations, 
dynamic reanimation of the face can only be achieved through 
the introduction of functional muscle units into the affected 
regions of the face.15–17 In addition to those procedures 
designed to reanimate the facial movements, a large number 
of procedures exist to provide static support to the paralyzed 
areas.14 Furthermore, in cases where the facial paralysis is 
localized to a particular region of the face, or to supplement 
previous surgical attempts, contralateral chemodenervation of 
the healthy facial musculature is a common treatment option 
to improve facial symmetry.18
Noninvasive treatment options are an essential adjunct 
to the aforementioned invasive techniques. With Bell’s palsy 
being the most common cause of facial paralysis and 70% 
of patients expected to return to normal facial function, non-
invasive treatments are often the only intervention required.3 
The early use of steroids in the management of Bell’s palsy 
is well established and simple techniques for ocular protec-
tion, such as eye taping at night and lubricating drops, would 
usually be commenced by a primary care physician.19,20 In 
those with more established facial paralysis, a spectrum of 
facial rehabilitation interventions exist with ongoing debate 
on their effectiveness as an isolated treatment.21,22 These range 
from stretching exercises and electrical stimulation through 
neuromuscular retraining.21,22
In addition to interventions that optimize the facial 
appearance and function, the psychosocial well-being of the 
patient must be considered. Facial expressions play a critical 
role in communicating emotions and affected individuals can 
be perceived as uninterested, unfriendly, or of lower intel-
ligence.23 Furthermore, facial asymmetry can be extremely 
disfiguring, thus stigmatizing the patient in a social setting.24 
In association with the disruption in psychosocial health, the 
prevalence of anxiety and depression in those with facial 
palsy is increased.25
Role of the MDT in facial palsy 
management
Central to a multidisciplinary approach to health care is col-
laboration between different subspecialties. This allows for 
the development of a comprehensive management plan for 
the patient and is now widely accepted as an effective means 
to approach patient care.26 Multidisciplinary care is now well 
established for many different conditions such as oncology,27 
diabetes,28 stroke,29 and burn care.30 This is based on the 
improved short- and long-term clinical outcomes31,32 and 
patient satisfaction.33 Despite these benefits, there remains 
inconclusive evidence that a multidisciplinary approach is 
cost-effective.34 This systematic review34 is, however, focused 
upon oncology-focused MDTs, where there will be signifi-
cant organizational and managerial costs relating to collation 
of the necessary medical records to facilitate discussion. 
Furthermore, costing outcomes such as patient satisfaction 
and function is very challenging in comparison to clearly 
defined outcome measures such as disease-free survival.34 
It is the former outcome domains that are most relevant to 
a facial palsy population, which would make evaluation of 
the cost-effectiveness of multidisciplinary care within this 
population challenging.
To provide holistic patient care to those affected by 
facial paralysis, high-volume units have established MDTs 
with the full breadth of expertise. Within our department, 
the core facial palsy MDT is led by a facial plastic surgeon 
who acts as the principal coordinator of the patient’s care. 
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Facial palsy health care
at first review, coordinating the time frame for any interven-
tions planned and ensuring the engagement and interaction 
of all members of the MDT. The additional members of the 
MDT include an oculoplastic surgeon, maxillofacial surgeon, 
physical therapist, speech therapist, psychologist, and medi-
cal photographer to offer the full repertoire of interventions 
previously discussed. Each new patient is reviewed in a 
bimonthly combined clinic with all members of the MDT 
present and then subsequent consultations are conducted by 
the necessary team members with the facial plastic surgeon 
overseeing the ongoing care pathway.
An MDT setup not only ensures that the patient has early 
access to the full repertoire of care but also serves to reduce 
the time accrued from ongoing patient referral.35 In cases of 
acquired facial palsy with minimal potential for spontaneous 
recovery, early surgical review can facilitate the introduc-
tion of treatment solutions that preserve the function of the 
native musculature. Such a step can significantly improve the 
resulting functional outcomes of the patient.8 Nonintegrated 
care can delay review by a suitable service and commit the 
patient to less-desirable interventions, such as free functional 
muscle transfer or static soft tissue support. Despite the 
proposed benefits,36–40 it should be noted that no objective 
studies have been performed to demonstrate that integrated, 
multidisciplinary care improves the long-term outcome of 
patients with facial palsy.
In addition to establishing the benefit of multidisciplinary 
care in the management of facial palsy, a further challenge 
facing the facial palsy MDT involves greater integration with 
primary care. The medical system in the UK involves patients 
presenting to their general practitioner in the first instance 
who will then introduce appropriate treatment and determine 
the need for referral to secondary care. This creates oppor-
tunity for delay in the referral of those who would benefit 
from early MDT input. Given the incidence of facial palsy, 
however, early referral of all patients with facial paralysis 
would create excessive burden on the resources of secondary 
care teams.41 Instead, the MDT should endeavor to produce 
appropriate guidance on referral pathways for clinicians42 
and exploit increasing patient engagement with the Internet 
by creating online educational material to empower patients 
in their care.43
Multidisciplinary collaboration in 
outcome measurement
Alongside direct patient care, health care professionals in the 
field of facial palsy must collaborate at an international level 
to advance patient care. The central focus of this  collaborative 
process should be to determine which measures best deter-
mine the outcome attained by the patient. Monitoring out-
comes allows evaluation of different treatments, providers, 
and even health care systems. It is, however, essential that 
outcome domains and measurement tools are chosen that 
offer a valid reflection of the outcome as perceived by the 
patient.
Recording patient outcomes is a central component of 
value-based health care as proposed by Porter.44 Optimizing 
patient outcome acts as a treatment objective that unifies the 
concerns of all stakeholders involved in patient care. Porter 
argues that “value is defined as the health outcomes achieved 
per dollar spent”.44 As such, resources can be focused upon 
the interventions that deliver greatest patient value.
In addition to improved value, outcome measurement 
allows greater comparison between treating units to identify 
those that can act as the benchmark for high-quality care. 
Others can then aim to replicate this care model in their 
respective institutions. A further benefit in standardizing 
outcome measurements is to improve the consistency in 
reporting clinical research outcomes. This would expedite 
the adoption of effective interventions.
The first stage in moving toward an outcome-centric 
approach in facial palsy care is to determine the outcome 
domains that matter most to patients. To address this aim, 
organizations such as the International Consortium for 
Health Outcome Measurements (ICHOM) have been cre-
ated. ICHOM is a not-for-profit organization established by 
Harvard University Institute for Strategy and Competitive-
ness, Boston Consulting Group, and the Karolinska Institute. 
A multidisciplinary, collaborative approach between health 
care professionals and patient representatives has been 
adopted by ICHOM.45 Through this approach, key outcome 
domains are identified and appropriate measurement tools 
selected. The inclusion of patient representatives ensures 
that the outcome domains chosen by the health care profes-
sionals are those that matter most to patients. A number of 
standardized outcome measurement sets have been created 
using this approach.46–48 Currently, an ICHOM-led program 
to standardize the outcome measurements in pediatric facial 
palsy care is underway.49
Following creation of a standardized facial palsy outcome 
measurement set, the MDT will have an important role in 
implementing the collection of the relevant data. This phase 
is likely to present a number of challenges in relation to the 
additional administrative burden arising from comprehen-
sive outcome measurement. Once routine data collection is 
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palsy, cross-collaboration and comparison will be essential 
to improve patient care. Holistic outcome measurement that 
focuses on the end point of patient care rather than each 
individual intervention is likely to reward greater multidis-
ciplinary working.
Conclusion
Facial palsy carries a significant functional and psychosocial 
burden. The etiological basis for facial paralysis is extensive 
and, as such, patients may present for primary review to a 
broad spectrum of health care professionals. Optimal care 
is, therefore, best delivered in a multidisciplinary capacity 
to ensure that the health care professionals collaborate to 
offer patients the full repertoire of treatment options at a 
time that best optimizes patient outcome. Facial palsy MDTs 
must also engage at an international level to determine what 
constitutes quality in the care of facial paralysis. From this, 
effective care pathways can be delineated and greater value 
delivered to the patient.
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